Developer docs
API playgroundTry for free, no card

Search company profiles

Clinical Research Partners

Full company profile

uuid000bt6e

Namestring
Clinical Research Partners
Legal namestring
Clinical Research Partners, LLC
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Clinical Research Partners is a private, founder-owned clinical research site organization headquartered in Richmond, Virginia, operating three sites across the greater Richmond-Petersburg-North Chesterfield corridor (Forest Avenue, Medical Park Blvd in Petersburg, and Koger Center Blvd in North Chesterfield). Founded in July 2011 by Dr. Robert S. Call, MD, CPI (President) and Annette Bennett (CEO) through the merger of Dr. Call's prior Commonwealth Clinical Research Specialists with Bennett's clinical research operations, the company conducts Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors across a broad non-oncology therapeutic footprint including allergy, vaccines, gastroenterology, endocrinology/metabolism, dermatology, neurology/pain, pediatrics, respiratory, infectious disease, urology, and women's health.

The company's core physical and operational infrastructure is purpose-built for early-phase and specialized work: an on-site peripheral blood mononuclear cell (PBMC) processing laboratory, a Class II Bio-Safety Cabinet (ISO Class 5) pharmacy, restricted-access investigational product storage with continuous digital temperature monitoring across 2-8°C, ambient, and -80°C/-70°C/-20°C ranges, 15 private exam rooms with sick/well separation, and infusion capability via its sister company Infusion Solutions. The medical director and several investigators hold ACRP Certified Principal Investigator credentials, and the broader investigator network is board-certified across family medicine, pediatrics, psychiatry, gastroenterology, dermatology, pulmonology, infectious disease, and women's health.

Revenue is generated almost entirely through negotiated per-study and per-visit site-services contracts with pharmaceutical and biotech sponsors, with Pfizer, Eli Lilly, and Supernus named as customers and an EVP of Contracts and Budgets leading sponsor negotiations. The site pursues a multi-channel go-to-market: direct-to-consumer recruitment via study landing pages and 24-hour phone lines, a $50-per-enrollment physician referral program plus formal partnerships with five regional medical practices, and an enterprise field-sales motion via a Director of Business Development. Participants are not required to have insurance and receive compensation for time and travel. No revenue, funding, or headcount figures are publicly disclosed.

Short descriptiontext

Clinical Research Partners is a private multi-site clinical research organization operating three locations in the greater Richmond, Virginia area, conducting Phase 1-4 trials across multiple therapeutic areas on behalf of pharmaceutical and biotech sponsors including Pfizer, Eli Lilly, and Supernus.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRichmond, United States
HQ citystring
Richmond
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial site services, phase 1-4 clinical trials, clinical research organization, patient recruitment services, investigational drug studies
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAGACAM
Clinical Trial Financial Management & Payments (Site Budgeting)
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Site Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical trial site services for pharmaceutical/biotech sponsors
TypeProfessional Services
Description

Generates revenue by contracting with pharmaceutical and biotech sponsors (e.g., Pfizer, Eli Lilly, Supernus) to conduct Phase 1–4 clinical trials at its three sites. Compensation typically comes via per-study budgets and per-visit fees negotiated by the EVP of Contracts and Budgets.

clinicalresearchrva.com
2Referral incentive program (outflow)
TypeAffiliate Referral
Description

Pays a $50 referral incentive per successful enrollment, funded out of site operating budget — this is an outflow, not a revenue stream.

clinicalresearchrva.com
Cost components6 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others
Pricing details3 tiers
1Volunteer compensation per study visit
ModelOther
Notes

Many studies offer monetary compensation to volunteers for time and travel; pay is commonly provided following every completed study visit. Specific amounts are not publicly disclosed.

clinicalresearchrva.com
2Sponsor contract pricing — quote-based
ModelOther
Notes

Site budgets and sponsor contracts are negotiated privately through the EVP of Contracts and Budgets; pricing is not publicly disclosed.

clinicalresearchrva.com
3Referral reward: $50 per successful enrollment
ModelOutcome Based/ Performance
Notes

Existing referrers receive $50 compensation for each referred individual who is new to CRP and successfully enrolls in a study.

clinicalresearchrva.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clinical Research Partners is a multi-site clinical research organization operating three Central Virginia sites that conduct Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors. The company recruits patient volunteers, runs investigational product pharmacy operations, performs on-site PBMC and PK processing, and administers study medications through an affiliated infusion center, while also providing regulatory, quality assurance, and study start-up services for sponsors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Clinical Research Partners is a single-service clinical research site organization (not a modular software platform) operating three locations across the greater Richmond, Virginia area (Forest Avenue in Richmond, Medical Park Blvd in Petersburg, and Koger Center Blvd in North Chesterfield). Founded in July 2011, the company conducts Phase 1 through Phase 4 clinical trials across multiple therapeutic areas as an integrated portfolio of enrolling studies. Its portfolio currently spans the Obesity Oral GLP-1 (EVOLVE-SWITCH), ADHD (SPN-812), Asthma, AVALON Celiac Disease (VTP-1000), C Diff Vaccine, Endometriosis (elaris EM-COC), Group B Strep Maternal Vaccine, Infant Pneumococcal Vaccine, Maternal RSV Vaccine (Pfizer ABRYSVO), Ulcerative Colitis, Diabetes Type 2 GLP-1, Crohn's Disease (STARSCAPE), SUNSCAPE Ulcerative Colitis, ATTAIN-PAD Peripheral Artery Disease, BALANCE IBS (camlipixant), Vitiligo (FPAD), and Pediatric Pneumococcal Vaccine studies. Supporting services include a Patient Forms intake process, a Patient Referral program offering $50 per successful enrollment, and Wellness Resources partnerships with Infusion Solutions and Vita Pure IV.

Product and service5 records
1Phase 1-4 Clinical Trial Site Services
CategoryClinical Trial Site Services
Description

End-to-end Phase 1 through Phase 4 clinical trial site services contracted by pharmaceutical and biotech sponsors (e.g., Pfizer, Eli Lilly, Supernus) across more than 15 therapeutic areas excluding oncology. Includes protocol execution, patient recruitment and enrollment, dosing, data capture, regulatory submissions, and quality assurance. Delivered from three Central Virginia sites (Forest Avenue/Richmond, Petersburg, North Chesterfield).

2PBMC / PK Laboratory Processing Services
CategorySpecialty Laboratory Services
Description

On-site peripheral blood mononuclear cell (PBMC) processing and pharmacokinetic (PK) laboratory services that allow sponsors to run PK and PBMC studies without shipping samples off-site. Supported by the company's GCP-compliant clinical infrastructure.

3Investigational Product Pharmacy Services
CategoryInvestigational Product Pharmacy
Description

Investigational product handling and storage under a Class II Bio-Safety Cabinet (ISO Class 5), including refrigerated (2-8°C) and ULT (-80°C/-70°C/-20°C) freezers with continuous digital temperature monitoring and restricted-access IP storage. Provided to sponsors whose protocols require controlled IP and biological-sample handling.

4Patient Referral Program
CategoryPatient Recruitment Services
Description

Formal physician referral program that pays $50 to referring clinicians for each referred individual who is new to CRP and successfully enrolls in a study. Backed by partnerships with regional medical practices (Mitchell Endoscopy Center, Virginia Physicians for Women, Virginia South Psychiatric & Family Services, Virginia Physicians Inc., Infusion Solutions).

5Volunteer Study Participation (Compensated)
CategoryClinical Trial Participation
Description

Consumer-facing study participation offered to local Richmond-area volunteers across active Phase 1-4 protocols. No insurance is required; participants receive free study-related care and monetary compensation for time and travel following each completed visit. Self-qualification via online patient forms, dedicated recruitment phone lines, 24-hour contact numbers, and email intake (Recruitment@ClinicalResearchRVA.com).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Velocity Clinical Research is one of the largest integrated site networks in the U.S., running Phase 1-4 trials across multiple therapeutic areas. Like CRP, it is an SMO-style operator that conducts trials for pharma/biotech sponsors; the difference is scale, with dozens of owned sites versus CRP's three Richmond-area locations.

TypeDirect peer
Description

Javara is an integrated clinical research site organization embedded within large medical practices, offering Phase 1-4 trials to pharma sponsors. It is directly comparable to CRP's hybrid model of running trials out of affiliated physician practices (Virginia Physicians for Women, Virginia South Psychiatric, etc.) and using physician referrals to drive enrollment.

TypeDirect peer
Description

Wake Research is a multi-site SMO network operating across the U.S. conducting Phase 1-4 clinical trials in vaccines, GI, endocrine, dermatology and other therapeutic areas. It is directly comparable to CRP because both operate dedicated research sites outside academic medical centers, run multi-specialty Phase 1-4 portfolios, and recruit via dedicated patient recruitment teams.

4Meridian Clinical Research
TypeDirect peer
Description

Meridian Clinical Research operates a network of dedicated clinical research sites in the Mid-Atlantic and Midwest, conducting Phase 1-4 trials across vaccines, dermatology, GI and endocrine indications. It is a comparable regional SMO peer with a similar multi-site, multi-therapeutic operating model and sponsor relationships (e.g., Pfizer, Lilly).

TypeDirect peer
Description

Benchmark Research is a multi-site SMO running Phase 2-4 trials across vaccines, dermatology, GI, women's health, and pediatrics from sites in Texas, Louisiana and California. It is comparable to CRP as an independent multi-specialty site network that recruits patients directly and runs sponsor-funded trials across a similar therapeutic breadth.

6Optimal Research
TypeDirect peer
Description

Optimal Research is a multi-site clinical research site organization running Phase 1-4 trials in vaccines, dermatology, women's health, and metabolic disease. It is directly comparable to CRP because both operate independent research-only sites, recruit via dedicated phone outreach, and run vaccine and GLP-1-style trials.

TypeDirect peer
Description

DM Clinical Research operates a network of dedicated research sites across the U.S. running Phase 1-4 trials for pharma sponsors. It is comparable to CRP as a multi-site SMO with a similar therapeutic portfolio, dedicated patient recruitment function, and dependence on top-decile PIs to attract sponsor contracts.

TypeEmerging player
Description

ClinEdge is a site network and clinical research services provider that operates dedicated sites and supports SMO operations. It is comparable to CRP because both serve as the operational and recruitment backbone for sponsor trials; ClinEdge adds a software/SaaS layer, whereas CRP is a pure site operator.

TypeBroad incumbent
Description

Pfizer operates internal Phase 1 clinical research units (e.g., New Haven, Brussels) for early-stage trials. As a top sponsor of CRP (Maternal RSV/ABRYSVO study), Pfizer represents both a customer and a broader incumbent running its own site-based clinical research operations in the same therapeutic categories CRP services.

TypeRegional player
Description

VCU Massey is an academic medical center-based clinical research site in Richmond, VA running sponsor-funded trials across a broad therapeutic portfolio. It is a comparable local peer to CRP that competes for sponsor work in the same Richmond geography, though its academic positioning and oncology coverage differ from CRP's independent community-based model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clinical Research Partners

Clinical Research Site Servicesclinicalresearchrva.com

Clinical Research Partners is a private multi-site clinical research organization operating three locations in the greater Richmond, Virginia area, conducting Phase 1-4 trials across multiple therapeutic areas on behalf of pharmaceutical and biotech sponsors including Pfizer, Eli Lilly, and Supernus.

What Clinical Research Partners does

Clinical Research Partners is a private, founder-owned clinical research site organization headquartered in Richmond, Virginia, operating three sites across the greater Richmond-Petersburg-North Chesterfield corridor (Forest Avenue, Medical Park Blvd in Petersburg, and Koger Center Blvd in North Chesterfield). Founded in July 2011 by Dr. Robert S. Call, MD, CPI (President) and Annette Bennett (CEO) through the merger of Dr. Call's prior Commonwealth Clinical Research Specialists with Bennett's clinical research operations, the company conducts Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors across a broad non-oncology therapeutic footprint including allergy, vaccines, gastroenterology, endocrinology/metabolism, dermatology, neurology/pain, pediatrics, respiratory, infectious disease, urology, and women's health.

The company's core physical and operational infrastructure is purpose-built for early-phase and specialized work: an on-site peripheral blood mononuclear cell (PBMC) processing laboratory, a Class II Bio-Safety Cabinet (ISO Class 5) pharmacy, restricted-access investigational product storage with continuous digital temperature monitoring across 2-8°C, ambient, and -80°C/-70°C/-20°C ranges, 15 private exam rooms with sick/well separation, and infusion capability via its sister company Infusion Solutions. The medical director and several investigators hold ACRP Certified Principal Investigator credentials, and the broader investigator network is board-certified across family medicine, pediatrics, psychiatry, gastroenterology, dermatology, pulmonology, infectious disease, and women's health.

Revenue is generated almost entirely through negotiated per-study and per-visit site-services contracts with pharmaceutical and biotech sponsors, with Pfizer, Eli Lilly, and Supernus named as customers and an EVP of Contracts and Budgets leading sponsor negotiations. The site pursues a multi-channel go-to-market: direct-to-consumer recruitment via study landing pages and 24-hour phone lines, a $50-per-enrollment physician referral program plus formal partnerships with five regional medical practices, and an enterprise field-sales motion via a Director of Business Development. Participants are not required to have insurance and receive compensation for time and travel. No revenue, funding, or headcount figures are publicly disclosed.

Clinical Research Partners firmographics

Firmographics
Name
Clinical Research Partners
Legal name
Clinical Research Partners, LLC
Website
https://clinicalresearchrva.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Clinical Research Partners is a private multi-site clinical research organization operating three locations in the greater Richmond, Virginia area, conducting Phase 1-4 trials across multiple therapeutic areas on behalf of pharmaceutical and biotech sponsors including Pfizer, Eli Lilly, and Supernus.
Ownership category
akta.pro rank

Clinical Research Partners industry classification

Industry
Product category
Clinical Research Site Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (62151)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAGACAM
Clinical Trial Financial Management & Payments (Site Budgeting)

Keywords

  • Clinical trial site services
  • Phase 1-4 clinical trials
  • Clinical research organization
  • Patient recruitment services
  • Investigational drug studies

Where Clinical Research Partners is headquartered

Location

Headquarters

HQ city
Richmond
HQ country
United States
HQ region
North America

Markets served

Clinical Research Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Clinical trial site services for pharmaceutical/biotech sponsors: Generates revenue by contracting with pharmaceutical and biotech sponsors (e.g., Pfizer, Eli Lilly, Supernus) to conduct Phase 1–4 clinical trials at its three sites. Compensation typically comes via per-study budgets and per-visit fees negotiated by the EVP of Contracts and Budgets.
  2. Referral incentive program (outflow): Pays a $50 referral incentive per successful enrollment, funded out of site operating budget — this is an outflow, not a revenue stream.

Pricing tiers

ModelBillingPrice
Other—Volunteer compensation per study visit
Other—Sponsor contract pricing — quote-based
Outcome Based/ Performance—Referral reward: $50 per successful enrollment

Go-to-market motion4 records

Clinical Research Partners product offering

Product offering

Core offering

Clinical Research Partners is a multi-site clinical research organization operating three Central Virginia sites that conduct Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors. The company recruits patient volunteers, runs investigational product pharmacy operations, performs on-site PBMC and PK processing, and administers study medications through an affiliated infusion center, while also providing regulatory, quality assurance, and study start-up services for sponsors.

Product overview

Clinical Research Partners is a single-service clinical research site organization (not a modular software platform) operating three locations across the greater Richmond, Virginia area (Forest Avenue in Richmond, Medical Park Blvd in Petersburg, and Koger Center Blvd in North Chesterfield). Founded in July 2011, the company conducts Phase 1 through Phase 4 clinical trials across multiple therapeutic areas as an integrated portfolio of enrolling studies. Its portfolio currently spans the Obesity Oral GLP-1 (EVOLVE-SWITCH), ADHD (SPN-812), Asthma, AVALON Celiac Disease (VTP-1000), C Diff Vaccine, Endometriosis (elaris EM-COC), Group B Strep Maternal Vaccine, Infant Pneumococcal Vaccine, Maternal RSV Vaccine (Pfizer ABRYSVO), Ulcerative Colitis, Diabetes Type 2 GLP-1, Crohn's Disease (STARSCAPE), SUNSCAPE Ulcerative Colitis, ATTAIN-PAD Peripheral Artery Disease, BALANCE IBS (camlipixant), Vitiligo (FPAD), and Pediatric Pneumococcal Vaccine studies. Supporting services include a Patient Forms intake process, a Patient Referral program offering $50 per successful enrollment, and Wellness Resources partnerships with Infusion Solutions and Vita Pure IV.

Differentiator

Problem solved

Functional benefit

Products and services

  • Phase 1-4 Clinical Trial Site Services End-to-end Phase 1 through Phase 4 clinical trial site services contracted by pharmaceutical and biotech sponsors (e.g., Pfizer, Eli Lilly, Supernus) across more than 15 therapeutic areas excluding oncology. Includes protocol execution, patient recruitment and enrollment, dosing, data capture, regulatory submissions, and quality assurance. Delivered from three Central Virginia sites (Forest Avenue/Richmond, Petersburg, North Chesterfield).
  • PBMC / PK Laboratory Processing Services On-site peripheral blood mononuclear cell (PBMC) processing and pharmacokinetic (PK) laboratory services that allow sponsors to run PK and PBMC studies without shipping samples off-site. Supported by the company's GCP-compliant clinical infrastructure.
  • Investigational Product Pharmacy Services Investigational product handling and storage under a Class II Bio-Safety Cabinet (ISO Class 5), including refrigerated (2-8°C) and ULT (-80°C/-70°C/-20°C) freezers with continuous digital temperature monitoring and restricted-access IP storage. Provided to sponsors whose protocols require controlled IP and biological-sample handling.
  • Patient Referral Program Formal physician referral program that pays $50 to referring clinicians for each referred individual who is new to CRP and successfully enrolls in a study. Backed by partnerships with regional medical practices (Mitchell Endoscopy Center, Virginia Physicians for Women, Virginia South Psychiatric & Family Services, Virginia Physicians Inc., Infusion Solutions).
  • Volunteer Study Participation (Compensated) Consumer-facing study participation offered to local Richmond-area volunteers across active Phase 1-4 protocols. No insurance is required; participants receive free study-related care and monetary compensation for time and travel following each completed visit. Self-qualification via online patient forms, dedicated recruitment phone lines, 24-hour contact numbers, and email intake (Recruitment@ClinicalResearchRVA.com).

Companies that use Clinical Research Partners

Customer profile

Ideal customer profiles2 records

Clinical Research Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Clinical Research Partners partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights5 records

Clinical Research Partners competitors and assessment

Company assessment

Direct peers

  • Velocity Clinical Research: Velocity Clinical Research is one of the largest integrated site networks in the U.S., running Phase 1-4 trials across multiple therapeutic areas. Like CRP, it is an SMO-style operator that conducts trials for pharma/biotech sponsors; the difference is scale, with dozens of owned sites versus CRP's three Richmond-area locations.
  • Javara: Javara is an integrated clinical research site organization embedded within large medical practices, offering Phase 1-4 trials to pharma sponsors. It is directly comparable to CRP's hybrid model of running trials out of affiliated physician practices (Virginia Physicians for Women, Virginia South Psychiatric, etc.) and using physician referrals to drive enrollment.
  • Wake Research: Wake Research is a multi-site SMO network operating across the U.S. conducting Phase 1-4 clinical trials in vaccines, GI, endocrine, dermatology and other therapeutic areas. It is directly comparable to CRP because both operate dedicated research sites outside academic medical centers, run multi-specialty Phase 1-4 portfolios, and recruit via dedicated patient recruitment teams.
  • Meridian Clinical Research: Meridian Clinical Research operates a network of dedicated clinical research sites in the Mid-Atlantic and Midwest, conducting Phase 1-4 trials across vaccines, dermatology, GI and endocrine indications. It is a comparable regional SMO peer with a similar multi-site, multi-therapeutic operating model and sponsor relationships (e.g., Pfizer, Lilly).
  • Benchmark Research: Benchmark Research is a multi-site SMO running Phase 2-4 trials across vaccines, dermatology, GI, women's health, and pediatrics from sites in Texas, Louisiana and California. It is comparable to CRP as an independent multi-specialty site network that recruits patients directly and runs sponsor-funded trials across a similar therapeutic breadth.
  • Optimal Research: Optimal Research is a multi-site clinical research site organization running Phase 1-4 trials in vaccines, dermatology, women's health, and metabolic disease. It is directly comparable to CRP because both operate independent research-only sites, recruit via dedicated phone outreach, and run vaccine and GLP-1-style trials.
  • DM Clinical Research: DM Clinical Research operates a network of dedicated research sites across the U.S. running Phase 1-4 trials for pharma sponsors. It is comparable to CRP as a multi-site SMO with a similar therapeutic portfolio, dedicated patient recruitment function, and dependence on top-decile PIs to attract sponsor contracts.

Emerging players

  • ClinEdge: ClinEdge is a site network and clinical research services provider that operates dedicated sites and supports SMO operations. It is comparable to CRP because both serve as the operational and recruitment backbone for sponsor trials; ClinEdge adds a software/SaaS layer, whereas CRP is a pure site operator.

Broad incumbents

  • Pfizer Clinical Research Unit: Pfizer operates internal Phase 1 clinical research units (e.g., New Haven, Brussels) for early-stage trials. As a top sponsor of CRP (Maternal RSV/ABRYSVO study), Pfizer represents both a customer and a broader incumbent running its own site-based clinical research operations in the same therapeutic categories CRP services.

Regional players

  • VCU Massey Comprehensive Cancer Center: VCU Massey is an academic medical center-based clinical research site in Richmond, VA running sponsor-funded trials across a broad therapeutic portfolio. It is a comparable local peer to CRP that competes for sponsor work in the same Richmond geography, though its academic positioning and oncology coverage differ from CRP's independent community-based model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Clinical Research Partners social profiles

Digital presence

Clinical Research Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clinical Research Partners leadership team

Management profile

Number of profiles

Profiles12 records

Clinical Research Partners subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Clinical Research Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clinical Research Partners M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Research Partners

What does Clinical Research Partners do?

Clinical Research Partners is a multi-site clinical research organization operating three Central Virginia sites that conduct Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors. The company recruits patient volunteers, runs investigational product pharmacy operations, performs on-site PBMC and PK processing, and administers study medications through an affiliated infusion center, while also providing regulatory, quality assurance, and study start-up services for sponsors.

Is Clinical Research Partners a public or private company?

Clinical Research Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Clinical Research Partners founded?

Clinical Research Partners was founded in 2011. It employs 11 to 50 people.

Where is Clinical Research Partners based?

Clinical Research Partners is headquartered in Richmond, United States, in the North America region.

How does Clinical Research Partners make money?

Two revenue lines are on record. Clinical trial site services for pharmaceutical/biotech sponsors are the primary driver. The others are referral incentive program (outflow).

Who are Clinical Research Partners's main competitors?

Direct peers on record are Velocity Clinical Research, Javara, Wake Research, Meridian Clinical Research, Benchmark Research, Optimal Research and DM Clinical Research. ClinEdge is listed as an emerging player. Pfizer Clinical Research Unit is listed as a broad incumbent. VCU Massey Comprehensive Cancer Center is listed as a regional player.

Does Clinical Research Partners have an API?

No public API is recorded for Clinical Research Partners.

What industry is Clinical Research Partners in?

Clinical Research Partners's product category is Clinical Research Site Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales